NCT02365597 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 101
- group Id
- BG003
- value
- 25
- group Id
- BG004
- value
- 237
- units
- Participants
- groups
- description
- Participants received single dose of erdafitinib 10 mg tablet, orally, once daily, starting from Day 1 through Day 7 and from Day 15 through Day 21 and so on, that is 7-day on and off in each subsequent 28-day cycles starting from Cycle 1. Based on serum phosphate (PO4) levels, there was an option to up-titrate erdafitinib dose to 12 mg, orally, once daily starting from Cycle 2 Day 1 until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG000
- title
- Main Study: Regimen 1: Erdafitinib 10 Milligrams (mg)/ 12 mg
- description
- Participants received single dose of erdafitinib 6 mg tablet, orally, once daily, starting from Day 1 through Day 28 in each subsequent 28-day cycles starting from Cycle 1. Based on serum PO4 levels, there was an option to up-titrate erdafitinib dose to 8 mg, orally, once daily starting from Cycle 2 Day 1 until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG001
- title
- Main Study: Regimen 2: Erdafitinib 6 mg/ 8 mg
- description
- Participants received single dose of erdafitinib 8 mg tablet, orally, once daily, starting from Day 1 through Day 28 in each subsequent 28-day cycles starting from Cycle 1. Based on serum PO4 levels, there was an option to up-titrate erdafitinib dose to 9 mg, orally, once daily starting from Cycle 1 Day 15 until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG002
- title
- Main Study: Regimen 3: Erdafitinib 8 mg/ 9 mg
- description
- Participants received pretreatment with single doses of midazolam 2.5 mg syrup orally on Day -2 and metformin 1000 mg tablet orally on Day -1 along with erdafitinib 8 mg tablet, orally, on 28-day cycles starting from Cycle 1 Day 1 to Day 15 (or up-titrated to 9 mg on Day 15 based on Day 14 serum PO4 levels) until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG003
- title
- Drug-Drug Interaction (DDI) Sub-study: Midazolam 2.5 mg + Metformin 1000 mg + Erdafitinib 8/9 mg
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 100
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 137
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.98
- value
- 68.6
- group Id
- BG001
- spread
- 10.36
- value
- 64.5
- group Id
- BG002
- spread
- 10.2
- value
- 66.1
- group Id
- BG003
- spread
- 10.35
- value
- 64.8
- group Id
- BG004
- spread
- 10.03
- value
- 65.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 69
- title
- Female
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 77
- group Id
- BG003
- value
- 15
- group Id
- BG004
- value
- 168
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 75
- group Id
- BG003
- value
- 22
- group Id
- BG004
- value
- 190
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 41
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 18
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 4
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 75
- group Id
- BG003
- value
- 20
- group Id
- BG004
- value
- 175
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- title
- More than one race
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 34
- title
- Unknown or Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 4
- title
- AUSTRIA
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 9
- title
- BELGIUM
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 37
- title
- FRANCE
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 11
- title
- GERMANY
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- title
- INDIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 5
- title
- ISRAEL
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 35
- title
- ITALY
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- MOLDOVA, REPUBLIC OF
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- ROMANIA
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 19
- title
- RUSSIAN FEDERATION
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 14
- title
- SOUTH KOREA
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 20
- group Id
- BG004
- value
- 39
- title
- SPAIN
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- Safety analysis set included participants who received at least 1 dose of study drug.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 78
- group Id
- BG002
- value
- 101
- group Id
- BG003
- value
- 25
- group Id
- BG004
- value
- 237
- units
- Participants
- groups
- description
- Participants received single dose of erdafitinib 10 mg tablet, orally, once daily, starting from Day 1 through Day 7 and from Day 15 through Day 21 and so on, that is 7-day on and off in each subsequent 28-day cycles starting from Cycle 1. Based on serum phosphate (PO4) levels, there was an option to up-titrate erdafitinib dose to 12 mg, orally, once daily starting from Cycle 2 Day 1 until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG000
- title
- Main Study: Regimen 1: Erdafitinib 10 Milligrams (mg)/ 12 mg
- description
- Participants received single dose of erdafitinib 6 mg tablet, orally, once daily, starting from Day 1 through Day 28 in each subsequent 28-day cycles starting from Cycle 1. Based on serum PO4 levels, there was an option to up-titrate erdafitinib dose to 8 mg, orally, once daily starting from Cycle 2 Day 1 until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG001
- title
- Main Study: Regimen 2: Erdafitinib 6 mg/ 8 mg
- description
- Participants received single dose of erdafitinib 8 mg tablet, orally, once daily, starting from Day 1 through Day 28 in each subsequent 28-day cycles starting from Cycle 1. Based on serum PO4 levels, there was an option to up-titrate erdafitinib dose to 9 mg, orally, once daily starting from Cycle 1 Day 15 until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG002
- title
- Main Study: Regimen 3: Erdafitinib 8 mg/ 9 mg
- description
- Participants received pretreatment with single doses of midazolam 2.5 mg syrup orally on Day -2 and metformin 1000 mg tablet orally on Day -1 along with erdafitinib 8 mg tablet, orally, on 28-day cycles starting from Cycle 1 Day 1 to Day 15 (or up-titrated to 9 mg on Day 15 based on Day 14 serum PO4 levels) until disease progression, unacceptable toxicity, or any other reason for treatment discontinuation.
- id
- BG003
- title
- Drug-Drug Interaction (DDI) Sub-study: Midazolam 2.5 mg + Metformin 1000 mg + Erdafitinib 8/9 mg
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 11
- group Id
- BG004
- value
- 100
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 14
- group Id
- BG004
- value
- 137
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.98
- value
- 68.6
- group Id
- BG001
- spread
- 10.36
- value
- 64.5
- group Id
- BG002
- spread
- 10.2
- value
- 66.1
- group Id
- BG003
- spread
- 10.35
- value
- 64.8
- group Id
- BG004
- spread
- 10.03
- value
- 65.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 69
- title
- Female
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 77
- group Id
- BG003
- value
- 15
- group Id
- BG004
- value
- 168
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 75
- group Id
- BG003
- value
- 22
- group Id
- BG004
- value
- 190
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 41
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 18
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 4
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 75
- group Id
- BG003
- value
- 20
- group Id
- BG004
- value
- 175
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- title
- More than one race
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 34
- title
- Unknown or Not Reported
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 3
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 4
- title
- AUSTRIA
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 9
- title
- BELGIUM
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 20
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 37
- title
- FRANCE
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 11
- title
- GERMANY
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 3
- title
- INDIA
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 5
- title
- ISRAEL
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 35
- title
- ITALY
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 1
- title
- MOLDOVA, REPUBLIC OF
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 2
- title
- ROMANIA
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 19
- title
- RUSSIAN FEDERATION
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 3
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 14
- title
- SOUTH KOREA
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 20
- group Id
- BG004
- value
- 39
- title
- SPAIN
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- Safety analysis set included participants who received at least 1 dose of study drug.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle